Related references
Note: Only part of the references are listed.Triptans: Low utilization and high turnover in the general population
A. Panconesi et al.
CEPHALALGIA (2010)
Sociodemographic and comorbidity profiles of chronic migraine and episodic migraine sufferers
D. C. Buse et al.
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2010)
The acute treatment of episodic and chronic migraine in the USA
M. E. Bigal et al.
CEPHALALGIA (2009)
Impact of Recent Prior Opioid Use on Rizatriptan Efficacy. A Post Hoc Pooled Analysis
Tony W. Ho et al.
HEADACHE (2009)
GERD prevalence in migraine patients and the implication for acute migraine treatment
Bozena J. Katic et al.
JOURNAL OF HEADACHE AND PAIN (2009)
Excessive opioid use and the development of chronic migraine
Marcelo E. Bigal et al.
PAIN (2009)
The Burden of Migraine in the United States: Current and Emerging Perspectives on Disease Management and Economic Analysis
Elisabeth Hazard et al.
VALUE IN HEALTH (2009)
Persistence with Migraine Prophylactic Treatment and Acute Migraine Medication Utilization in the Managed Care Setting
Avin Z. Yaldo et al.
CLINICAL THERAPEUTICS (2008)
Migraine-associated risks and comorbidity
H. C. Diener et al.
JOURNAL OF NEUROLOGY (2008)
Chronic migraine in the population - Burden, diagnosis, and satisfaction with treatment
Marcelo E. Bigal et al.
NEUROLOGY (2008)
Excessive acute migraine medication use and migraine progression
Marcelo E. Bigal et al.
NEUROLOGY (2008)
Medication compliance and persistence: Terminology and definitions
Joyce A. Cramer et al.
VALUE IN HEALTH (2008)
Patterns of triptans use: a study based on the records of a community pharmaceutical department
E. Pavone et al.
CEPHALALGIA (2007)
Distinguishing patterns in the dynamics of long-term medication use by Markov analysis: beyond persistence
Tanja T. Menckeberg et al.
BMC HEALTH SERVICES RESEARCH (2007)
Acute migraine treatment: Patterns of use and satisfaction in a clinical population
SN Malik et al.
HEADACHE (2006)
Obesity and migraine - A population study
ME Bigal et al.
NEUROLOGY (2006)
EFNS guideline on the drug treatment of migraine - report of an EFNS task force
S. Evers et al.
EUROPEAN JOURNAL OF NEUROLOGY (2006)
Exacerbation of migraine attacks during treatment with the selective serotonin reuptake inhibitor sertraline -: A case report
A Bickel et al.
PHARMACOPSYCHIATRY (2005)
Removing barriers to appropriate migraine treatment: Formulary limitations and triptan package size
SD Silberstein et al.
HEADACHE (2005)
Patterns of specific antimigraine drug use - a study based on the records of 18 community pharmacies
JJHM Lohman et al.
CEPHALALGIA (2005)
Cardiovascular tolerability and safety of triptans: A review of clinical data
DW Dodick et al.
HEADACHE (2004)
Switching patients with migraine from sumatriptan to other triptans increases primary care costs
N Savani et al.
INTERNATIONAL JOURNAL OF CLINICAL PRACTICE (2004)
Migraine headache misconceptions: Barriers to effective care
R Wenzel et al.
PHARMACOTHERAPY (2004)
Single use of sumatriptan: A patient interview study
H Rahimtoola et al.
HEADACHE (2003)
Pharmacologic management of acute attacks of migraine and prevention of migraine headache
V Snow et al.
ANNALS OF INTERNAL MEDICINE (2002)
Prevalence and burden of migraine in the United States: Data from the American Migraine Study II
RB Lipton et al.
HEADACHE (2001)
Share Paper
